New Director General of the Danish Medicines Agency

11 January 2016

The Danish Ministry of Health has appointed Thomas Senderovitz as Director General of the newly established Danish Medicines Agency.

A man with a strong international profile and extensive knowledge of the pharmaceutical industry will head the newly established Danish Medicines Agency. Thomas Senderovitz holds an MD from the University of Copenhagen and has been working with medicinal products on an international level during the past 15 years – most recently as a member of the management team of the global CRO (Contract Research Organisation) PAREXEL in Berlin.

”I am very satisfied that we have appointed Thomas Senderovitz as Director General of the Danish Medicines Agency. He has strong professional skills, and with his drive and extensive experience he will create a new medicines agency that will be able to support the Danish pharmaceutical and medical device industries in the best possible way, while at the same time monitoring companies closely,” says Minister for Health Sophie Løhde.

Thomas Senderovitz will take up the position as Director General of the Danish Medicines Agency on 1 April 2016 and is looking forward to working at the agency.

”I am very pleased to have the opportunity to head the newly established agency, because it provides unique opportunities to start afresh. And I am looking forward to making efforts to ensure that the Danish Medicines Agency further improves its strong professional level and to enhance focus on our international collaboration,” says Thomas Senderovitz, who also points out that the advice offered to companies must be strengthened.

”We will strengthen our interaction with the sector, for example by reducing assessment times and setting a higher standard for scientific advice, that is advice to companies in connection with the testing and licensing of medicinal products. I am also looking forward to heading an agency that works to ensure that effective and safe medicinal products are available to citizens,” says Thomas Senderovitz.

The Danish Medicines Agency was established as an independent agency on 8 October 2015 after having formed part of the Danish Health and Medicines Authority from 2012 to 2015.

About Thomas Senderovitz

Thomas Senderovitz is 50 years old and received his MD from the University of Copenhagen in 1992.

His career includes more than 15 years working intensively with medicinal products and he has held several senior positions in international biopharmaceutical companies (Ferring Pharmaceuticals, UCB Pharma, Grünenthal GmbH). Most recently, Thomas Senderovitz was a member of the management team of the global CRO (Contract Research Organisation) PAREXEL engaging in clinical research for pharmaceutical and biotechnological companies.

Thomas Senderovitz previously worked at the Clinical Pharmacological Department at Bispebjerg Hospital in Copenhagen and was a medical secretary in the former Danish Medicines Agency.

He has two children aged 14 and 24 and is married to Mette Wibeck Olsen.

Thomas Senderovitz

Download, high resolution (JPEG)

Photographer: Jesper Ludvigsen

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.